BCSF vs HRZN: Which BDC is the Better Dividend Buy?

A side-by-side comparison of Bain Capital Specialty Finance, Inc. (BCSF) and Horizon Technology Finance Corporation (HRZN) — dividend yield, NAV premium/discount, market cap, and price-to-NAV valuation.

BCSF
Bain Capital Specialty Finance, Inc.
NYSE Quarterly Div
HRZN
Horizon Technology Finance Corporation
NASDAQ Monthly Div

Ready to Trade BCSF or HRZN?

Public Disclosure: We maintain material affiliate partnerships with the trading platforms listed below and may receive compensation if you open an account through our tracking routes.

Compare BDC dividend yields side-by-side, then open a brokerage account that supports fractional shares and real-time distribution tracking.

eToro ★ Best for Commission-Free Fractional BDC Shares
Trade BCSF or HRZN on eToro →
Interactive Brokers (IBKR) ★ Best for Advanced Yield & Asset Coverage Analysis
Invest in BCSF / HRZN via IBKR →

BCSF vs HRZN: Key Metrics Head-to-Head

MetricBCSFHRZNEdge
Dividend Yield14.89%24.25%HRZN
Premium / Discount to NAV-23.09%-47.64%BCSF
Market Capitalization$0.72B$0.2BBCSF
Trailing Stock Price$12.69$4.66
Net Asset Value (NAV)$16.5$8.9
Price vs NAV (Valuation)DiscountDiscountBCSF
Dividend FrequencyQuarterlyMonthly
Leverage Ratio1.2x1.3xBCSF

About BCSF — Bain Capital Specialty Finance, Inc.

Bain Capital Specialty Finance, Inc. is an externally managed BDC advised by Bain Capital Credit, with a focus on senior secured first lien and unitranche loans to U.S. middle-market companies. BCSF leverages Bain Capital's global credit platform to source directly originated loans to companies with EBITDA between $5 million and $50 million. The portfolio is concentrated in floating-rate first lien instruments designed to perform across interest-rate cycles.

View Full BCSF Profile →

About HRZN — Horizon Technology Finance Corporation

Horizon Technology Finance Corporation is an externally managed BDC focused on venture debt and secured loans to venture-backed companies in the technology, life sciences, and healthcare industries. HRZN structures loans in the $2 million to $25 million range and supplements interest income with equity warrants to enhance risk-adjusted returns. The portfolio is concentrated in pre-IPO and rapidly growing venture-stage borrowers.

View Full HRZN Profile →

How to Choose Between BCSF and HRZN

When comparing two Business Development Companies, the right choice depends on your income objective:

  • Dividend yield matters most for immediate income — the higher yielder wins on cash flow, but make sure it's covered by investment income.
  • NAV premium/discount matters for valuation — a discount to NAV implies you're buying assets below their accounting value, a premium implies the market expects above-average growth.
  • Market cap reflects liquidity and scale — larger BDCs typically have lower borrowing costs and better portfolio diversification.
  • Leverage cuts both ways — it amplifies dividend yield but increases sensitivity to credit defaults and interest rate moves.

Both BCSF and HRZN are Regulated Investment Company (RIC)-structured BDCs required to distribute at least 90% of taxable income to shareholders, which is what produces their above-average dividend yields. Use the comparison table above as a starting point, then read each full profile before making an investment decision.

Affiliate Disclosure: BusinessDevelopmentCompanies.com participates in affiliate marketing programs. We may earn a commission or referral fee when visitors click links to institutional partner platforms like eToro or Interactive Brokers. This financial support enables us to maintain real-time programmatic valuation data across our platform. Links to brokerages on this page carry the rel="sponsored nofollow noopener" attribute.

Not Investment Advice: This comparison is for educational and informational purposes only. Nothing here constitutes a recommendation, solicitation, or investment advice to buy or sell any security. Past performance does not guarantee future results. Always conduct your own due diligence and consult a licensed financial advisor. Read our full Editorial Policy and Terms of Service.